Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2008 May 06; 70(19):1699-706.

View in: PubMed

subject areas

Botulinum Toxins
Clinical Trials as Topic
Dystonic Disorders
Essential Tremor
Evidence-Based Medicine
Humans
Movement Disorders
Muscle, Skeletal
Neuromuscular Blocking Agents
Treatment Outcome

authors with profiles

Cynthia Comella